CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

of customers agree our service is more convenient than ordering via a GP The new NHS Electronic Prescription Service (EPS) means all your repeat prescriptions can now be arranged and delivered free ...

With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating ...

Q3 2025 Management View Revenue for the quarter grew 18% to $95.3B, with adjusted operating profit increasing 16% to $1.5B. CEO Brian Tyler highlighted strong performance across the U.S.

McKesson's third-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.